If You Can’t Join ‘Em, Beat ‘Em: New Industry Effort A Jab At Patent Pool?
A new pharmaceutical industry initiative aimed at improving access to HIV treatments in least-developed countries is raising questions as to how it will fit with the Medicines Patent Pool, an existing group with a similar mandate. As an informal meeting on the new initiative kicks off this week in New Delhi, scrutiny will be paid to whether the initiative’s drivers are several companies that have declined to negotiate with the patent pool and whether it is a good-faith effort to help the greatest number of patients.
